Trevi Therapeutics, Inc. TRVI Exercised (in shares)
Exercised (in shares) at other companies
Other financials
Where this comes from
Reported directly by Trevi Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice.
The official record: Trevi Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Trevi Therapeutics, Inc.'s exercised (in shares).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Trevi Therapeutics, Inc.'s exercised (in shares)?
- Trevi Therapeutics, Inc. (TRVI) reported exercised (in shares) of $2.11 in Q1 2026.
- How has Trevi Therapeutics, Inc.'s exercised (in shares) changed year-over-year?
- Trevi Therapeutics, Inc.'s exercised (in shares) decreased by 14.6% year-over-year, from $2.47 to $2.11.
- What does exercised (in shares) mean?
- The weighted average exercise price at which employees and directors exercised their stock options during the period. This provides insight into the historical price levels at which equity incentives were realized by participants.